CPH.TO · Cipher Pharmaceuticals Inc.
Canada · RS rating 18 · As of 2026-10-14
| Price | 13.35 CAD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 30 / 15 / 34 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 20 / 15 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | -37.5% |
| Sales growth Q/Q | -3.5% |
| Distance from 52-week high | +32.4% |
| Market cap (USD) | $243.9M |